Biora Therapeutics Inc
NASDAQ:BIOR

Watchlist Manager
Biora Therapeutics Inc Logo
Biora Therapeutics Inc
NASDAQ:BIOR
Watchlist
Price: 0.22 USD Market Closed
Market Cap: 994.4k USD

Intrinsic Value

BIOR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BIOR stock under the Base Case scenario is 5.81 USD. Compared to the current market price of 0.22 USD, Biora Therapeutics Inc is Undervalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIOR Intrinsic Value
5.81 USD
Undervaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

No research report yet

Want a deep‑dive on Biora Therapeutics Inc?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Biora Therapeutics Inc’s research
View All Researches
Biora Therapeutics Inc
NASDAQ:BIOR
US
Health Care
Market Cap
994.4k USD
IPO
Jun 19, 2020
US
Health Care
Market Cap
994.4k USD
IPO
Jun 19, 2020
Price
$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Biora Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biora Therapeutics Inc

Current Assets 6.1m
Cash & Short-Term Investments 3.2m
Receivables 868k
Other Current Assets 2m
Non-Current Assets 8.5m
PP&E 2.2m
Intangibles 6.1m
Other Non-Current Assets 193k
Efficiency

Free Cash Flow Analysis
Biora Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biora Therapeutics Inc

Revenue
892k USD
Operating Expenses
-61.8m USD
Operating Income
-60.9m USD
Other Expenses
29.3m USD
Net Income
-31.5m USD
Fundamental Scores

BIOR Profitability Score
Profitability Due Diligence

Biora Therapeutics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Exceptional ROE
40/100
Profitability
Score

Biora Therapeutics Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

BIOR Solvency Score
Solvency Due Diligence

Biora Therapeutics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Long-Term Solvency
Short-Term Solvency
22/100
Solvency
Score

Biora Therapeutics Inc's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOR Price Targets Summary
Biora Therapeutics Inc

There are no price targets for BIOR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Biora Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BIOR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BIOR Insider Trading
Buy and sell transactions by insiders